Mechanistic studies unravel the complexity inherent in tau aggregation leading to Alzheimer's disease and the tauopathies.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Biochemistry

• Publication date

  2013-06-06

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/bi400209zPMID 23721410
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aminothienopyridazines and Methylene Blue Affect Tau Fibrillization via Cysteine Oxidation*

  2013cited by this paper
• Mechanistic basis of phenothiazine-driven inhibition of Tau aggregation.

  2013cited by this paper
• β-Sheet core of tau paired helical filaments revealed by solid-state NMR.

  2012cited by this paper
• FTDP-17 tau mutations induce distinct effects on aggregation and microtubule interactions.

  2012cited by this paper
• Prion-like spread of protein aggregates in neurodegeneration

  2012cited by this paper
• Trans-Synaptic Spread of Tau Pathology In Vivo

  2012cited by this paper
• Identification of an aggregation-prone structure of tau.

  2012cited by this paper
• Biochemistry and cell biology of tau protein in neurofibrillary degeneration.

  2012cited by this paper
• Taxol-stabilized microtubules promote the formation of filaments from unmodified full-length Tau in vitro

  2012cited by this paper
• Trans-cellular Propagation of Tau Aggregation by Fibrillar Species*

  2012cited by this paper
• Evidence for the existence of a secondary pathway for fibril growth during the aggregation of tau.

  2012cited by this paper
• Propagation of tau pathology in a model of early Alzheimer's disease.

  2012cited by this paper
• Small Misfolded Tau Species Are Internalized via Bulk Endocytosis and Anterogradely and Retrogradely Transported in Neurons*

  2012cited by this paper
• Tau alternative splicing in familial and sporadic tauopathies.

  2012cited by this paper
• Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo

  2012cited by this paper
• Tau Isoform Composition Influences Rate and Extent of Filament Formation*

  2012cited by this paper
• In situ measurements of the formation and morphology of intracellular β-amyloid fibrils by super-resolution fluorescence imaging.

  2011cited by this paper
• Are Tangles as Toxic as They Look?

  2011cited by this paper
• Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease

  2011cited by this paper
• Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice

  2011cited by this paper
• Characterization of Prefibrillar Tau Oligomers in Vitro and in Alzheimer Disease*

  2011cited by this paper
• Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation

  2011cited by this paper
• The many faces of tau.

  2011cited by this paper
• S3‐03‐05: Transmission and Spreading of Tauopathy in Transgenic Mouse Brain

  2011cited by this paper
• Understanding the Kinetic Roles of the Inducer Heparin and of Rod-like Protofibrils during Amyloid Fibril Formation by Tau Protein*

  2011cited by this paper
• Secondary nucleating sequences affect kinetics and thermodynamics of tau aggregation.

  2011cited by this paper
• Systems neuroscience: The stress of dieting

  2011cited by this paper
• Tau-Induced Defects in Synaptic Plasticity, Learning, and Memory Are Reversible in Transgenic Mice after Switching Off the Toxic Tau Mutant

  2011cited by this paper
• Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease

  2011cited by this paper
• "Lest we forget you--methylene blue...".

  2011cited by this paper
• Caspase activation precedes and leads to tangles

  2010cited by this paper
• Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden

  2010cited by this paper
• Tau Potentiates Nerve Growth Factor-induced Mitogen-activated Protein Kinase Signaling and Neurite Initiation without a Requirement for Microtubule Binding*

  2010cited by this paper
• Nuclear Tau, a Key Player in Neuronal DNA Protection*

  2010cited by this paper
• Characterization of tau fibrillization in vitro

  2010cited by this paper
• Human Tau Isoforms Assemble into Ribbon-like Fibrils That Display Polymorphic Structure and Stability*

  2010cited by this paper
• Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models.

  2010cited by this paper
• Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration.

  2010cited by this paper
• The role of the lipid bilayer in tau aggregation.

  2010cited by this paper
• Model discrimination and mechanistic interpretation of kinetic data in protein aggregation studies.

  2009cited by this paper
• Transmission and spreading of tauopathy in transgenic mouse brain

  2009cited by this paper
• Activated Actin-Depolymerizing Factor/Cofilin Sequesters Phosphorylated Microtubule-Associated Protein during the Assembly of Alzheimer-Like Neuritic Cytoskeletal Striations

  2009cited by this paper
• Identification of aminothienopyridazine inhibitors of tau assembly by quantitative high-throughput screening.

  2009cited by this paper
• Tau Aggregation Followed by Atomic Force Microscopy and Surface Plasmon Resonance, and Single Molecule Tau-Tau Interaction Probed by Atomic Force Spectroscopy

  2009cited by this paper
• Developmental regulation of tau phosphorylation, tau kinases, and tau phosphatases

  2009cited by this paper
• Structural Polymorphism of 441-Residue Tau at Single Residue Resolution

  2009cited by this paper
• Propagation of Tau Misfolding from the Outside to the Inside of a Cell*

  2009cited by this paper
• Chemical Manipulation of Hsp70 ATPase Activity Regulates Tau Stability

  2009cited by this paper
• Molecular mechanisms for protein-encoded inheritance

  2009cited by this paper
• The transcellular spread of cytosolic amyloids, prions, and prionoids.

  2009cited by this paper
• Quantitative Characterization of Heparin Binding to Tau Protein

  2009cited by this paper
• Protein aggregation kinetics, mechanism, and curve-fitting: a review of the literature.

  2009cited by this paper
• Fibril Fragmentation Enhances Amyloid Cytotoxicity*♦

  2009cited by this paper
• Conformational Diversity of Wild-type Tau Fibrils Specified by Templated Conformation Change*

  2009cited by this paper
• Nucleation-dependent Tau Filament Formation

  2008cited by this paper
• Axonal Transport Rates In Vivo Are Unaffected by Tau Deletion or Overexpression in Mice

  2008cited by this paper
• Neuron-specific recombination by Cre recombinase inserted into the murine tau locus.

  2008cited by this paper
• Membrane‐bound β‐amyloid oligomers are recruited into lipid rafts by a fyn‐dependent mechanism

  2008cited by this paper
• Function and structure of inherently disordered proteins.

  2008cited by this paper
• Domain conformation of tau protein studied by solution small-angle X-ray scattering.

  2008cited by this paper
• Pathogenic missense MAPT mutations differentially modulate tau aggregation propensity at nucleation and extension steps

  2008cited by this paper
• Characterization of Alzheimer's-like paired helical filaments from the core domain of tau protein using solid-state NMR spectroscopy.

  2008cited by this paper
• A soluble oligomer of tau associated with fiber formation analyzed by NMR.

  2008cited by this paper
• Differential Regulation of Dynein and Kinesin Motor Proteins by Tau

  2008cited by this paper
• The Potential for β-Structure in the Repeat Domain of Tau Protein Determines Aggregation, Synaptic Decay, Neuronal Loss, and Coassembly with Endogenous Tau in Inducible Mouse Models of Tauopathy

  2008cited by this paper
• The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments.

  2008cited by this paper
• Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly

  2008cited by this paper
• Fitting neurological protein aggregation kinetic data via a 2-step, minimal/"Ockham's razor" model: the Finke-Watzky mechanism of nucleation followed by autocatalytic surface growth.

  2008cited by this paper
• Phosphorylation Regulates Tau Interactions with Src Homology 3 Domains of Phosphatidylinositol 3-Kinase, Phospholipase Cγ1, Grb2, and Src Family Kinases*

  2008cited by this paper
• Hope in Alzheimer's fight emerges from unexpected places

  2008cited by this paper
• Anesthesia Leads to Tau Hyperphosphorylation through Inhibition of Phosphatase Activity by Hypothermia

  2007cited by this paper
• Atomic structures of amyloid cross-β spines reveal varied steric zippers

  2007cited by this paper
• Taurine, an inducer for tau polymerization and a weak inhibitor for amyloid-beta-peptide aggregation.

  2007cited by this paper
• A complex mechanism for inducer mediated tau polymerization.

  2007cited by this paper
• Granular tau oligomers as intermediates of tau filaments.

  2007cited by this paper
• Non‐native protein aggregation kinetics

  2007cited by this paper
• Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo

  2007cited by this paper
• Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model.

  2007cited by this paper
• Fiber-dependent amyloid formation as catalysis of an existing reaction pathway

  2007cited by this paper
• Molecular chaperone‐mediated tau protein metabolism counteracts the formation of granular tau oligomers in human brain

  2007cited by this paper
• Inhibition of tau aggregation in cell models of tauopathy.

  2007cited by this paper
• Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model

  2007cited by this paper
• The “Jaws” of the Tau-Microtubule Interaction*

  2007cited by this paper
• Protein aggregation processes: In search of the mechanism

  2007cited by this paper
• Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy

  2007cited by this paper
• Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

  2007cited by this paper
• Atomic structures of amyloid cross-beta spines reveal varied steric zippers.

  2007cited by this paper
• Side Chain-dependent Stacking Modulates Tau Filament Structure*

  2006cited by this paper
• Preparation of amyloid beta-protein for structural and functional studies.

  2006cited by this paper
• Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer's disease.

  2006cited by this paper
• The core of tau-paired helical filaments studied by scanning transmission electron microscopy and limited proteolysis.

  2006cited by this paper
• Untangling the tau gene association with neurodegenerative disorders.

  2006cited by this paper
• Global hairpin folding of tau in solution.

  2006cited by this paper
• Structural impact of heparin binding to full-length Tau as studied by NMR spectroscopy.

  2006cited by this paper
• Structure of core domain of fibril-forming PHF/Tau fragments.

  2006cited by this paper
• Preparation of amyloid β-protein for structural and functional studies

  2006cited by this paper
• Anthraquinones Inhibit Tau Aggregation and Dissolve Alzheimer's Paired Helical Filaments in Vitro and in Cells*

  2005cited by this paper
• Cell-Cycle Reentry and Cell Death in Transgenic Mice Expressing Nonmutant Human Tau Isoforms

  2005cited by this paper
• Evaluating triggers and enhancers of tau fibrillization

  2005cited by this paper
• Triggers of full-length tau aggregation: a role for partially folded intermediates.

  2005cited by this paper

• Integrating the Multiscale Molecular Modelling Techniques in Identification of Rat-TTBK1 Inhibitors from Glycyrrhiza glabra Plant: Homology-Modelling, Docking, MD Simulation, PCA Analysis, Cluster Analysis and MMGB/SA Study

  2025cites this paper
• Tungsten disulphide nanosheet modulated fluorescent gold nanocluster immunoprobe for the detection of tau peptide: Alzheimer's disease biomarker.

  2025cites this paper
• Untangling Tau: Molecular Insights into Neuroinflammation, Pathophysiology, and Emerging Immunotherapies

  2023cites this paper
• New cyclopentaquinoline and 3,5-dichlorobenzoic acid hybrids with neuroprotection against oxidative stress for the treatment of Alzheimer’s disease

  2023cites this paper
• Elongation of Fibrils Formed by a Tau Fragment is Inhibited by a Transient Dimeric Intermediate.

  2022cites this paper
• Heterogeneity in Protein Folding and Unfolding Reactions.

  2022cites this paper
• Mechanistic role of boswellic acids in Alzheimer's disease: Emphasis on anti-inflammatory properties.

  2021cites this paper
• Efferocytosis in multisystem diseases

  2021cites this paper
• The Lys 280 → Gln mutation mimicking disease‐linked acetylation of Lys 280 in tau extends the structural core of fibrils and modulates their catalytic properties

  2021cites this paper
• Human Polymerase δ-Interacting Protein 2 (PolDIP2) Inhibits the Formation of Human Tau Oligomers and Fibrils

  2021cites this paper
• Tau and MAPT genetics in tauopathies and synucleinopathies.

  2021cites this paper
• The Dynamism of Intrinsically Disordered Proteins: Binding-Induced Folding, Amyloid Formation, and Phase Separation.

  2020cites this paper
• Boswellic Acids as Promising Leads in Drug Development against Alzheimer’s Disease

  2020cites this paper
• Tau protein- induced sequestration of the eukaryotic ribosome: Implications in neurodegenerative disease

  2020cites this paper
• Role of cysteines in accelerating Tau filament formation

  2020cites this paper
• Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies

  2020cites this paper
• The protein–surfactant stoichiometry governs the conformational switching and amyloid nucleation kinetics of tau K18

  2020cites this paper
• Liquid-Liquid Phase Separation is Driven by Large-Scale Conformational Unwinding and Fluctuations of Intrinsically Disordered Protein Molecules

  2019cites this paper
• 14-3-3/Tau Interaction and Tau Amyloidogenesis

  2019cites this paper
• Mechanistic approaches to understand the prion-like propagation of aggregates of the human tau protein.

  2019cites this paper
• Stochastic Considerations into the Origins of Sporadic Adult Onset Neurodegenerative Disorders

  2019cites this paper
• Mechanistic Insight into Tau Fibril Cross-Seeding Barriers: Structural Order and Disorder

  2019influential citation
• Insight into the Structure of the "Unstructured" Tau Protein.

  2019cites this paper
• Controlled fluorescence quenching by antibody-conjugated graphene oxide to measure tau protein

  2018cites this paper
• Acetylation Disfavors Tau Phase Separation

  2018cites this paper
• Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies.

  2017cites this paper
• Tau Positron Emission Tomography Imaging.

  2017cites this paper
• Inferring Mechanistic Parameters from Amyloid Formation Kinetics by Approximate Bayesian Computation.

  2017cites this paper
• Fourier Transform Infrared (FTIR) Spectroscopy, Ultraviolet Resonance Raman (UVRR) Spectroscopy, and Atomic Force Microscopy (AFM) for Study of the Kinetics of Formation and Structural Characterization of Tau Fibrils.

  2017cites this paper
• Protein folding, misfolding and aggregation: The importance of two-electron stabilizing interactions

  2017cites this paper
• Inert and seed-competent tau monomers suggest structural origins of aggregation

  2017cites this paper
• Protein Aggregation and Neurodegeneration: Tauopathies and Synucleinopathies

  2017cites this paper
• Glycerol inhibits the primary pathways and transforms the secondary pathway of insulin aggregation.

  2016cites this paper
• How Does Hyperphopsphorylation Promote Tau Aggregation and Modulate Filament Structure and Stability?

  2016cites this paper
• The ordered assembly of tau is the gain‐of‐toxic function that causes human tauopathies

  2016cites this paper
• An evolutionary roadmap to the microtubule-associated protein MAP Tau

  2016cites this paper
• The twisted tauopathies: surface interactions of helically patterned filaments seen in alzheimer's disease and elsewhere.

  2016cites this paper
• Développement préclinique de sondes fluorées utilisées dans l'imagerie moléculaire des pathologies neurodégénératives

  2015cites this paper
• Synthesis, biological evaluation and molecular modeling of new tetrahydroacridine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.

  2015cites this paper
• Assembly and Disassembly of Protein Aggregates

  2015cites this paper
• Chemical Modulators of Protein Misfolding, Neurodegeneration and Tau: What is not Covered Next

  2015cites this paper
• Cellular factors modulating the mechanism of tau protein aggregation

  2015cites this paper
• Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future.

  2015cites this paper
• Presence of Phosphorylated Tau Protein in the Skin of Alzheimer´s Disease Patients

  2015cites this paper
• Hirano bodies differentially modulate cell death induced by tau and the amyloid precursor protein intracellular domain

  2014cites this paper
• Generation and diagnostic valorisation of monoclonal antibodies for human protein tau

  2014influential citation
• Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-Modifying Drugs. Update 2014

  2014cites this paper
• Paths to Alzheimer's disease prevention: From modifiable risk factors to biomarker enrichment strategies

  2014cites this paper
• Resonance Raman spectroscopic measurements delineate the structural changes that occur during tau fibril formation.

  2014cites this paper
• TAM receptor tyrosine kinases: expression, disease and oncogenesis in the central nervous system.

  2014cites this paper
• Thermodynamics of the Interaction between Alzheimer's Disease Related Tau Protein and DNA

  2014cites this paper
• Accelerating the clearance of mutant huntingtin protein aggregates through autophagy induction by europium hydroxide nanorods.

  2014cites this paper
• The role of the medial temporal lobe in discriminating complex object and scene stimuli

  2013cites this paper
• Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs

  2013cites this paper
• Difference in fibril core stability between two tau four-repeat domain proteins: a hydrogen-deuterium exchange coupled to mass spectrometry study.

  2013cites this paper
• Identification and characterization of innate immune receptor substrates of γ-secretase enzyme complex

  2013cites this paper